Latest Attention-deficit hyperactivity disorder Stories
Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events.
Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use BOSTON, July 9, 2014 /PRNewswire-USNewswire/ -- Over the last 60 years, the U.S.
LOS ANGELES, July 9, 2014 /PRNewswire/ -- NeuroSigma, Inc.
Working memory in children is linked strongly to reading and academic achievement.
Psychologists at the University of Bonn are amazed by the severe deficits caused by a sleepless night
Bio Stimulants in Foliar Market report provides insights into competitive landscape, main players, their strategic directives, operational strengths, key selling products -
North American Bio Stimulants market can be segmented by Companies, Endusers, Applications and MacroIndicators.
Researchers at the University of Copenhagen and the Copenhagen University Hospital have identified a particular genetic mutation that may cause parkinsonism in young people.
BCC Research (http://www.bccresearch.com) is pleased to announce the BCC Research Strattera® Forecast, a strategic investment product
Harbor Village Florida comments on a new report that shows that ADHD is likely to lead to drug abuse. USA (PRWEB) July 02, 2014 As reported by CBS News
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.